Abcellera Biologics shares owned by Tower Research Capital
Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by Tower Research Capital
from 13F filings
Historical chart of Tower Research Capital investment in Abcellera Biologics
Tip: Access up to 7 years of quarterly data
All positions including Abcellera Biologics held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Abcellera Biologics by Tower Research Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $20k | 4.4k | 4.53 |
| 2023-09-30 | $39k | 8.5k | 4.60 |
| 2023-06-30 | $314k | 49k | 6.46 |
| 2023-03-31 | $41k | 5.4k | 7.61 |
| 2022-12-31 | $143k | 14k | 10.13 |
| 2022-09-30 | $155k | 16k | 9.88 |
| 2022-06-30 | $167k | 16k | 10.65 |
| 2022-03-31 | $15k | 1.6k | 9.63 |
| 2021-12-31 | $12k | 802 | 15.38 |
| 2021-09-30 | $30k | 1.5k | 20.22 |
| 2021-06-30 | $1.0k | 68 | 14.71 |
| 2021-03-31 | $116k | 3.5k | 33.33 |
| 2020-12-31 | $12k | 354 | 33.33 |
More positions owned by Tower Research Capital
Home Depot (HD)
View all positions for Tower Research Capital